ZOETIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.9 USD | +0.57% |
|
+0.25% | -14.44% |
| May. 08 | HSBC Adjusts Price Target on Zoetis to $225 From $230 | MT |
| May. 06 | BNP Paribas Exane Adjusts Price Target on Zoetis to $232 From $237 | MT |
ETFs positioned on Zoetis Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 23 M€ | -.--% | - | |
| 0.20% | 7 M€ | +6.18% | - | |
| 0.20% | 32 M€ | +1.80% | - | |
| 0.20% | 17 M€ | +6.18% | - | |
| 0.20% | 57 M€ | +21.00% | - | |
| 0.19% | 4 M€ | -.--% | - | |
| 0.18% | 14 M€ | +16.19% | - | |
| 0.17% | 1,487 M€ | +7.21% | - | |
| 0.17% | 283 M€ | +19.85% | ||
| 0.17% | 1 M€ | +3.03% | - | |
| 0.15% | 607 M€ | +0.05% | - | |
| 0.15% | 1,166 M€ | +0.26% | - | |
| 0.14% | 205 M€ | -.--% | ||
| 0.13% | 571 M€ | +7.35% | - | |
| 0.13% | 20 M€ | +1.32% | - | |
| 0.13% | 0 M€ | 0.00% | - | |
| 0.11% | 34 M€ | +8.28% | - | |
| 0.11% | 9 M€ | +9.41% | ||
| 0.11% | 9 M€ | +9.94% | - | |
| 0.10% | 391 M€ | +8.80% | - | |
| 0.09% | 15 M€ | -1.62% | - | |
| 0.08% | 306 M€ | +6.13% | - | |
| 0.08% | 39 M€ | +5.31% | - | |
| 0.08% | 45 M€ | 0.00% | - | |
| 0.06% | 17 M€ | +2.84% | - | |
| 0.06% | 17 M€ | +4.20% | - |
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
168.9
USD
Average target price
211
USD
Spread / Average Target
+24.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.44% | 77.05B | |
| +25.88% | 3.73B | |
| +1.39% | 3.33B | |
| +17.06% | 1.69B | |
| -8.82% | 1.52B | |
| -22.51% | 1.3B | |
| -2.93% | 1.27B | |
| -10.11% | 1.18B | |
| +4.27% | 1.09B | |
| -7.06% | 1B |
- Stock Market
- Equities
- ZTS Stock
- Funds and ETFs Zoetis Inc.